$GATO
Gatos Silver, Inc.

2023 Q3 Form 10-Q Financial Statement

#000110465923088937 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.490M $6.130M $4.260M
YoY Change 26.31% 43.9% -3.42%
% of Gross Profit
Research & Development $0.00 $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization $0.00 $30.00K $50.00K
YoY Change -100.0% -40.0% 1150.0%
% of Gross Profit
Operating Expenses $7.497M $6.160M $4.300M
YoY Change 25.43% 43.26% -15.88%
Operating Profit
YoY Change
Interest Expense $9.110M $1.290M $8.640M
YoY Change 3.64% -85.07% -52.76%
% of Operating Profit
Other Income/Expense, Net $1.348M $1.094M $1.110M
YoY Change 25.28% -1.44% 255.77%
Pretax Income $3.288M -$3.593M $5.571M
YoY Change -18.39% -164.49% -58.71%
Income Tax $0.00 $0.00 $340.0K
% Of Pretax Income 0.0% 6.1%
Net Earnings $3.288M -$3.593M -$2.426M
YoY Change 73.05% 48.1% -117.98%
Net Earnings / Revenue
Basic Earnings Per Share $0.05 -$0.05 -$0.04
Diluted Earnings Per Share $0.05 -$0.05 -$0.04
COMMON SHARES
Basic Shares Outstanding 69.16M 69.16M 69.16M
Diluted Shares Outstanding 69.52M shares 69.16M 69.16M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.50M $9.100M $7.300M
YoY Change 118.95% 24.66% -75.34%
Cash & Equivalents $33.47M $9.139M $7.277M
Short-Term Investments
Other Short-Term Assets $15.94M $15.68M $2.222M
YoY Change 1379.57% 605.58% 1.46%
Inventory
Prepaid Expenses $816.0K $1.633M $1.347M
Receivables
Other Receivables
Total Short-Term Assets $50.50M $26.98M $10.08M
YoY Change 198.25% 167.78% -72.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $328.7M $354.3M $342.6M
YoY Change -3.63% 3.42% 38.52%
Other Assets $42.00K $44.00K $48.00K
YoY Change 7.69% -8.33% 0.0%
Total Long-Term Assets $328.8M $354.3M $374.7M
YoY Change -11.5% -5.43% 51.46%
TOTAL ASSETS
Total Short-Term Assets $50.50M $26.98M $10.08M
Total Long-Term Assets $328.8M $354.3M $374.7M
Total Assets $379.3M $381.3M $384.8M
YoY Change -2.36% -0.9% 35.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.075M $484.0K $198.0K
YoY Change 21.2% 144.44% -46.34%
Accrued Expenses $4.200M $2.749M $618.0K
YoY Change 1063.43% 344.82% -69.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.40M $25.70M $1.300M
YoY Change 1047.83% 1876.92% -65.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $8.700M $12.70M
YoY Change -100.0% -31.5%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $8.700M $12.70M
YoY Change -100.0% -31.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.40M $25.70M $1.300M
Total Long-Term Liabilities $0.00 $8.700M $12.70M
Total Liabilities $26.40M $34.40M $14.00M
YoY Change 74.83% 145.71% 270.27%
SHAREHOLDERS EQUITY
Retained Earnings -$198.2M -$201.5M -$174.5M
YoY Change 14.87% 15.5% 28.7%
Common Stock $117.0K $117.0K $117.0K
YoY Change 0.0% 0.0% 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $352.9M $346.9M $370.7M
YoY Change
Total Liabilities & Shareholders Equity $379.3M $381.3M $384.8M
YoY Change -2.36% -0.9% 35.21%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $3.288M -$3.593M -$2.426M
YoY Change 73.05% 48.1% -117.98%
Depreciation, Depletion And Amortization $0.00 $30.00K $50.00K
YoY Change -100.0% -40.0% 1150.0%
Cash From Operating Activities -$1.670M -$3.770M $2.020M
YoY Change -120.9% -286.63% -254.79%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $30.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $35.00M $0.00
YoY Change
Cash From Investing Activities $35.00M $0.00 -$30.00K
YoY Change -100.0% -98.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.000M 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.670M -3.770M 2.020M
Cash From Investing Activities 35.00M 0.000 -30.00K
Cash From Financing Activities -9.000M 0.000 0.000
Net Change In Cash 24.33M -3.770M 1.990M
YoY Change 204.51% -289.45% -239.26%
FREE CASH FLOW
Cash From Operating Activities -$1.670M -$3.770M $2.020M
Capital Expenditures $0.00 $0.00 $30.00K
Free Cash Flow -$1.670M -$3.770M $1.990M
YoY Change -120.9% -289.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001517006
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
548313000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
547114000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-201507000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39649
dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
424-0984
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GATO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9139000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17004000
CY2023Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2162000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1773000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
15678000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
26979000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
35648000
CY2023Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
354273000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
347793000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60000
CY2023Q2 us-gaap Assets
Assets
381296000
CY2022Q4 us-gaap Assets
Assets
383501000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
25656000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2023Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
8717000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
8661000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198749000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
346923000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381296000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
383501000
us-gaap Exploration Expense
ExplorationExpense
26000
us-gaap Exploration Expense
ExplorationExpense
110000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6127000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11663000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11034000
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
71000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
6161000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
4301000
us-gaap Costs And Expenses
CostsAndExpenses
11760000
us-gaap Costs And Expenses
CostsAndExpenses
11232000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1474000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8762000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6485000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15597000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1094000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1110000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2517000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2256000
CY2023Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
2568000
CY2022Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
9872000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
9002000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
17853000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3593000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5571000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2758000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6621000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3593000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5231000
us-gaap Net Income Loss
NetIncomeLoss
-2758000
us-gaap Net Income Loss
NetIncomeLoss
6281000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
783000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
835000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
350100000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
416000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3593000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
346923000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
331222000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1482000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
333754000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-250000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5231000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
338735000
us-gaap Profit Loss
ProfitLoss
-2758000
us-gaap Profit Loss
ProfitLoss
6281000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
71000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
us-gaap Share Based Compensation
ShareBasedCompensation
1205000
us-gaap Share Based Compensation
ShareBasedCompensation
1360000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
127000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
6485000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
15597000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
6275000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
389000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1016000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-648000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-198000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1139000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1336000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7865000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
688000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7865000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
661000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17004000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9139000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7277000
us-gaap Interest Paid Net
InterestPaidNet
364000
us-gaap Interest Paid Net
InterestPaidNet
227000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1633000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2890000
CY2023Q2 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000
CY2022Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000
CY2023Q2 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
129000
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
816000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
730000
CY2022Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
151000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
15678000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
484000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
586000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2749000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2761000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1356000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1889000
CY2023Q2 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2022Q4 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
25656000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
462000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-228000
us-gaap Share Based Compensation
ShareBasedCompensation
1205000
us-gaap Share Based Compensation
ShareBasedCompensation
1360000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3593000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5231000
us-gaap Net Income Loss
NetIncomeLoss
-2758000
us-gaap Net Income Loss
NetIncomeLoss
6281000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
gato Incremental Common Shares Attributable To Dilutive Effect Of Deferred Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfDeferredShareUnits
146796
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6127000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
34000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1474000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8762000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1094000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1110000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
CY2023Q2 us-gaap Assets
Assets
381296000
CY2022Q2 us-gaap Assets
Assets
352765000
us-gaap Exploration Expense
ExplorationExpense
26000
us-gaap Exploration Expense
ExplorationExpense
110000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11663000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11034000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
71000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6485000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15597000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2517000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2256000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
340000
CY2023Q2 us-gaap Assets
Assets
381296000
CY2022Q2 us-gaap Assets
Assets
352765000

Files In Submission

Name View Source Status
0001104659-23-088937-index-headers.html Edgar Link pending
0001104659-23-088937-index.html Edgar Link pending
0001104659-23-088937.txt Edgar Link pending
0001104659-23-088937-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20230630.xsd Edgar Link pending
gato-20230630x10q.htm Edgar Link pending
gato-20230630x10q003.jpg Edgar Link pending
gato-20230630xex31d1.htm Edgar Link pending
gato-20230630xex31d2.htm Edgar Link pending
gato-20230630xex32d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gato-20230630x10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gato-20230630_pre.xml Edgar Link unprocessable
gato-20230630_cal.xml Edgar Link unprocessable
gato-20230630_lab.xml Edgar Link unprocessable
gato-20230630_def.xml Edgar Link unprocessable